ClinicalTrials.Veeva

Menu

Empathy and Virtual Reality (VR)

University of Miami logo

University of Miami

Status

Begins enrollment this month

Conditions

Fear
Virtual Reality

Treatments

Behavioral: Fear-inducing Virtual Reality (VR) experience
Behavioral: Neutral Virtual Reality (VR) experience

Study type

Interventional

Funder types

Other

Identifiers

NCT07314788
20241195

Details and patient eligibility

About

This study will characterize the subjective and physiological changes associated with empathy following a fear-inducing virtual reality (VR) experience.

Enrollment

110 estimated patients

Sex

All

Ages

18 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • College-aged adults (18-25 years old)
  • English-speaking
  • Normal or corrected vision.
  • Able to provide consent.

Exclusion criteria

• Presence of a significant and/or unstable medical illness (e.g., cardiovascular disease, cancer, neurological disorder) or head trauma (e.g., concussion).

Additional exclusion criteria apply to virtual reality (VR):

  • VR contraindications: epilepsy, migraines, flu, sleep deprivation, etc.
  • More than minimal VR experience assessed via self-report (e.g., How often have you used virtual reality in the past? 0=never, 6=very frequently)
  • Extreme phobia of heights and/or spiders will be assessed using Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) specific phobia subscale.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

110 participants in 2 patient groups

Fear-inducing Virtual Reality (VR) experience
Experimental group
Description:
Participants will complete a single virtual reality (VR) exposure lasting approximately 1-2 minutes, involving a fear-inducing scenario (e.g., walking a plank above a high-rise building or canyon).
Treatment:
Behavioral: Fear-inducing Virtual Reality (VR) experience
Neutral Virtual Reality (VR) experience
Active Comparator group
Description:
Participants will complete a single virtual reality (VR) exposure lasting approximately 1-2 minutes, involving a neutral scenario (e.g., walking to the edge of a curb at street level).
Treatment:
Behavioral: Neutral Virtual Reality (VR) experience

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Britton, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems